Bloodstream Infection Testing Market Set To Valuable Growth Rate, Production Overview and Development Technologies by 2031 | AB Sciex, IRIDICA, Abbot Laboratories, Cepheid Inc

Market Overview:

Bloodstream infection testing helps in the diagnosis of the presence of pathogens or microbial infection in the bloodstream. The tests are conducted using blood culture methods that allow detection of microorganisms in the blood.

Market Dynamics:

Rising prevalence of bloodstream infections and growing healthcare spending are expected to drive the market growth over the forecast period. According to the Centers for Disease Control and Prevention (CDC), approximately 270,000 cases of bloodstream infections occur annually in the United States. This increasing prevalence of bloodstream infections has increased the demand for effective diagnostic solutions. Furthermore, growing healthcare spending in developing countries is also expected to fuel the market growth during the forecast period. The advanced features of automated blood culture systems such as continuous monitoring, rapid detection, automated alerts and reporting functions have gained popularity over conventional blood culture systems. Advancements in blood culture techniques with improved antibiotic susceptibility reporting are also expected to support the market growth in coming years.

Request Sample Copy of the Report at: - https://www.coherentmarketinsights.com/insight/request-sample/1727

List of TOP Players in Market Report are: -

◘ BioMérieux SA
◘ Becton
◘ Dickinson and Company
◘ AB Sciex
◘ IRIDICA
◘ Abbot Laboratories
◘ Cepheid Inc.
◘ C. R. Bard Inc.
◘ F. Hoffmann-La Roche AG
◘ Nanoshpere
◘ Dade Behring
◘ AdvanDX
◘ Siemens Healthcare.

Growing Demand for Early Diagnosis and Rapid Detection of BSI Drives the Market

The increasing demand for early diagnosis and rapid detection of bloodstream infections is a major driver for the bloodstream infection testing market. Traditional blood culturing techniques can take 24-72 hours to detect pathogens which leads to delay in appropriate antibiotic therapy. This delay in detection and treatment results in increased morbidity, mortality, and healthcare costs. Rapid diagnostic tests that can detect pathogens directly from blood within hours are addressing this need for early diagnosis. Their ability to provide results much faster than conventional blood cultures allows for prompt administration of targeted antibiotic therapy. This in turn leads to improved patient outcomes and reduced healthcare costs.

Rise in Antimicrobial Resistance Presents a Challenge

The rising antimicrobial resistance among various pathogens has emerged as a key challenge for the bloodstream infection testing market. Widespread and often inappropriate use of antibiotics over the past decades has contributed significantly to the growth and spread of multidrug-resistant organisms. These resistant pathogens are difficult to treat effectively using conventional antibiotics. This significantly reduces treatment options and increases mortality rates. The limited development of new classes of antibiotics in recent years has further exacerbated the problem. Pathogens resistant to last resort antibiotics like carbapenems are increasingly being reported worldwide. This makes rapid and accurate detection of resistant strains more important than ever to optimize antibiotic therapy.

Buy This Premium Report and Get Upto 25 % OFF: https://www.coherentmarketinsights.com/insight/buy-now/1727

Opportunity for Development of Molecular Diagnostic Tests

The increasing adoption of molecular diagnostic techniques like PCR and next generation sequencing provides new opportunities for bloodstream infection testing market players. Molecular tests can detect a broad range of pathogens directly from blood in fewer hours compared to blood cultures. They also enable early identification of antimicrobial resistance genes in infecting pathogens. This helps initiate targeted therapy sooner. Continuous technological advancements are making molecular assays easier to use at the point-of-care. The development and commercialization of rapid, affordable, and accurate molecular diagnostic tests for bloodstream infections can significantly improve patient outcomes.

Growing Demand for Antimicrobial Stewardship Programs Drives Market Innovation

The rising demand for antimicrobial stewardship programs in healthcare facilities worldwide is a major trend in the bloodstream infection testing market. These programs aim to optimize antibiotic use and reduce antimicrobial resistance. Rapid and accurate detection of bloodstream pathogens plays a pivotal role in enabling timely review of antibiotic regimens and de-escalation of therapy when appropriate. This contributes to better patient outcomes as well as reduced consumption of broad-spectrum antibiotics. Leading marker players are continuously innovating and introducing novel diagnostic solutions that facilitate effective implementation of stewardship programs. Syndromic multiplex panels, advanced machine learning tools and cloud-based reporting are some areas witnessing progressive developments.

Furthermore, the years considered for the study are as follows:

Historical data - 2016-2022
The base year for estimation - is 2022
Estimated Year - 2024
Forecast period** - 2024 to 2031

This Bloodstream Infection Testing Market Research/Analysis Report Contains Answers to your following Questions:

◈What are the current global trends in the Bloodstream Infection Testing market, and will the market experience an increase or decrease in demand in the upcoming years?

◈ What is the expected demand for various product types within the Bloodstream Infection Testing market, and what are the emerging Market applications and trends?

◈ What are the projections for the global Bloodstream Infection Testing Market in terms of capacity, production, production value, cost, profit, market share, supply, consumption, import, and export?

◈ How will strategic developments shape the Market trajectory in the medium to long term?

◈ What factors contribute to the final price of Bloodstream Infection Testing , and what are the raw materials used in its manufacturing?

◈ What is the market's growth potential, particularly with the increasing adoption of Bloodstream Infection Testing in mining?

◈ What is the current and 2022 value of the global market, and who are the leading companies in this market?

◈ What recent Market trends can be leveraged to create additional revenue streams?

◈ What entry strategies, economic impact mitigation measures, and marketing channels should be considered for the Bloodstream Infection Testing Market?

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/1727

Summarized Extracts from TOC of Market Study

Chapter 1 Bloodstream Infection Testing Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of Bloodstream Infection Testing

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the Bloodstream Infection Testing industry

1.4 Methodology of The Study

1.5 Research Data Source

Chapter 2 Executive Summary

Chapter 3 Industry Chain Analysis

Chapter 4 Market, by Type

Chapter 5 Market, by Application

Chapter 6 Market Analysis by Regions

Chapter 7 North America Market Analysis by Countries

Chapter 8 Europe Bloodstream Infection Testing Market Analysis by Countries

Chapter 9 Asia Pacific Bloodstream Infection Testing Market Analysis by Countries

Chapter 10 Middle East and Africa Bloodstream Infection Testing Market Analysis by Countries

Chapter 11 South America Bloodstream Infection Testing Market Analysis by Countries

Chapter 12 Competitive Landscape

Chapter 13 Industry Outlook

Chapter 14 Market Forecast

Chapter 15 New Project Feasibility Analysis

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.